He Fought Claims of Harm From Infant Formula. Now He Regulates It.
Kyle Diamantas, a former corporate lawyer, is the new director for the F.D.A. food division, which oversees infant formula.
Zacks Investment Research on MSN1d
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
The most recent trading session ended with Abbott (ABT) standing at $130.28, reflecting a -1.79% shift from the previouse trading day's closing. This change lagged the S&P 500's 0.49% gain on the day.
Food Safety News1mon
Legislation would increase safety of infant formula, help decrease shortages
An Abbott Nutrition manufacturing plant was later found to have had systemic contamination with the bacteria. The company recalled Similac and other major brands of its infant formula, causing a ...
Just-Food2y
Abbott Laboratories faces SEC, FTC investigation over infant formula shortage
US infant-formula manufacturer Abbott Laboratories is facing investigations by the Securities and Exchange Commission (SEC) and the Federal Trade Commission (FTC), documents show. The company ...
Zacks Investment Research on MSN2d
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. If we consider the ...
Abbott, Apple, Citi, Nexstar, Musk, OpenAI: Votes and Verdicts
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...